Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date How Digitization Can Improve Bioprocessing and Make Manufacturing More Robust Charlotte Masy at GSK Vaccines and Ciaran O’Keeffe at MasterControl Presented by Charlotte Masy, Senior Manager in Manufacturing Science and Technology GSK Vaccines and Ciaran O’Keeffe, Director, Business Development &... 6 days ago | 78 mins Evaluation of Optimal Extraction Conditions for Polypropylene, PBT Resins... Daniel Norwood, at Feinberg Norwood & Associates Pharma Consulting and Lothar Habel PhD, at Nelson Labs Europe Full title: Evaluation of Optimal Extraction Conditions for Polypropylene, PBT Resins, and Chlorobutyl Rubber Elastomer - Using a Variety of Solvents ... October 4, 2023 2:00pm Ruggedness and Robustness in Nitrosamine Analysis from Pharmaceutical Elastomers Jason Creasey, at Maven E&L Ltd and Ank Reumer, at Nelson Labs Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Ank Reumer, Senior Study Director, Quantitative Methods Team at Nelson Labs This w... 4 weeks ago | 109 mins Insights into Practical Issues Associated with Extractables Testing... Dennis Jenke, Chief Executive Scientist at Triad Scientific Solutions Full title: Insights into Practical Issues Associated with Extractables Testing of Medical Devices It is a well-known adage that “the devil is in the... December 5, 2023 3:00pm Toxicological Risk Assessment on Extractables and Leachables Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals January 16, 2024 3:00pm Safety Evaluation on Extractables and Leachable Dr Clemens Günther, at Bayer AG, R&D Pharmaceuticals and Tino Otte at Intertek Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals 11 months ago | 159 mins Handling mutagenic extractable and leachable compounds released from devices Ron Brown, Toxicologist at Risk Science Consortium and Piet Christieans, PhD, Scientific Director at Nelson Labs Genotoxic compounds can be released from some medical devices during their clinical use. The ISO 10993-17:2002 standard outlines steps to assess the ... 2 years ago | 115 mins The Importance of Accurate Chemical Characterization of Medical Devices... Ron Brown, Toxicologist at Risk Science Consortium and Dries Cardoen, PhD, Sr. E&L Expert – Team leader at Nelson Labs Full title: The Importance of Accurate Chemical Characterization of Medical Devices Extractables Chemical characterization of medical devices, involv... 11 months ago | 134 mins Mass Transport Modelling in support of leachable risk management. Thomas Egert at Boehringer Ingelheim Pharma and Jason Creasey at Maven E&L Ltd Leachable risk management continues to be of regulatory interest. However we continue to rely on experimental extractable studies as predictors of lea... 9 months ago | 103 mins Sanofi’s and SGS’S Implementation of BPOG’S Leachable Risk Assessment model... Ken Wong, Deputy Director at Sanofi Pasteur and Dujuan Lu, Manager/Global Lead of Extractables & Leachables at SGS Full Title: Case Study and Experience on Sanofi's and SGS's Implementation of BPOG's Leachable Risk Assessment Model and Extractable Testing Protocol ... 4 years ago | 89 mins Load more